Periodic Reporting for period 2 - CRYSTAL3 (Commercial & Research Opportunity for Cysteinyl Leukotriene Signalling in Ocular & CNS Dysfunction, Cancer and Cardiovascular Disease)

Millions of people worldwide suffer from diseases that impose significant health and economic burdens. Ocular disorders, including blindness and vision impairment, affect over 2.5 billion people, costing Europe around €20 billion annually. Neurological diseases, such as...